Mindfulness program for chronic graft-versus-host disease symptoms
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests whether a mindfulness program can help reduce symptoms and improve quality of life for people living with chronic graft-versus-host disease (cGVHD). You would attend group sessions (in person or virtual) to learn mindfulness techniques.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older
- You have been diagnosed with moderate or severe chronic graft-versus-host disease (cGVHD)
- You are willing to attend group sessions, either in person or online
- You can read and understand English
- You have not had a major increase in your cGVHD medication in the last 4 weeks
- You have not already participated in 4 or more sessions of mindfulness-based therapy (MBSR or MBCT)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a pill called belumosudil to see if it can help people with chronic graft-versus-host disease (a common complication after a stem cell transplant where donor cells attack your body). It is for patients who have symptoms but are not yet on strong immune-suppressing drugs.
This study looks at immune cells in your blood and in tissues affected by chronic graft-versus-host disease (a condition where donor cells attack your body) after a stem cell transplant. By analyzing samples, researchers hope to better understand this condition and improve future treatments.
This study looks at immune cells in tissues affected by chronic graft-versus-host disease (cGVHD), a common complication after a stem cell transplant. It aims to better understand the condition, which may lead to better treatments.
This trial tests whether a mindfulness program, offered through faith communities, can help Black adult cancer survivors feel better and manage stress. It involves attending group sessions and completing online surveys.
This study tests an online mindfulness program (stress-reducing techniques) to help people with cancer who live in rural areas feel better emotionally. It is designed for those who are feeling significant distress.
This study tests an oral medication called belumosudil for people who have chronic graft-versus-host disease (cGVHD) after a stem cell transplant. It aims to see how safe the drug is. You may qualify if you have already tried at least two other treatments and are currently on a stable steroid dose.
Hear when a new Chronic Graft Versus Host Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.